Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lippo Karawaci Tbk. (LPKR) vs Merck Tbk. (MERK) Price & Performance

Lippo Karawaci Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Lippo Karawaci Tbk. vs Merck Tbk. — how do they compare? Lippo Karawaci Tbk. trades at Rp63 (market cap 4.25T, 148.64M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Lippo Karawaci Tbk. is far larger — about 2.5× Merck Tbk.'s market cap, and Lippo Karawaci Tbk. is more actively traded (148.64M versus 37.6K). Which is the better fit depends on your goals.

LPKRMERK
Market Cap
4.25T1.7T
Volume
148.64M37.6K
Lot
1.49M376
Turnover
9.21B144.47M
Average Price
61.953,842.23
Value
9.21B144.47M
Indicative Equilibrium Price
633,840
Indicative Equilibrium Volume
18.08K7

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LPKR
View details
MERK
View details

About Lippo Karawaci Tbk.

PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.

Read more on LPKR

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK